Success Story: We Helped a Postdoctoral Associate from Poland Secure NIW Approval with Our Expert Guidance
Client’s Testimonial:
“Very prompt replies, professional interaction, clear instructions, and high-quality documents prepared by the attorneys assigned to my case. Thank you all!”
On April 22nd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Microbiology (Approval Notice).
General Field: Microbiology
Position at the Time of Case Filing: Postdoctoral Associate
Country of Origin: Poland
State of Residence at the Time of Filing: California
Approval Notice Date: April 22nd, 2025
Processing Time: 1 year, 4 months, 4 days
Case Summary:
We are pleased to announce the approval of a National Interest Waiver (NIW) petition for a PhD holder in biological science whose work is transforming the field of microbiology. The petition was filed in 2023 and approved after 16 months and 4 days without receiving any RFE.
The client’s research focuses on the development of synthetic antibodies with enhanced functional activity against infectious agents. This work aims to improve disease prevention and treatment, especially for conditions like HIV, through antibody engineering strategies that offer potent, long-acting solutions. Such technologies address a persistent public health concern while supporting efforts to lower disease transmission, treatment costs, and healthcare burdens.
To date, the client has authored 8 peer-reviewed journal articles, a book chapter, and a preprint - many of which are published in high-impact journals. Their work has been cited 64 times, including in top-tier scientific literature, and at least two of their papers rank among the most-cited in the field of microbiology for their publication years. The client has also served as a peer reviewer for reputable journals, completing over 5 reviews.
In our petition, we demonstrated the client’s scientific influence by highlighting how their methods have been adopted globally to advance topics ranging from vaccine development to genetic manipulation of pathogens. Their work has received funding from prominent agencies such as NIH, NSF, and NASA, underscoring its national relevance. The petition was supported by two letters of recommendation from respected experts in the field.
“Clearly, [Client] is advancing understanding of microbial pathogenesis and enhancing the development of targeted therapeutics by identifying molecular mechanisms implicated in the survival of bacteria within a human host—contributions that strongly establish his role as a predominant member of the microbiology field.”
We are honored to support this accomplished scientist in continuing their work at the intersection of immunology and infectious disease.